Magna GenetX BPC-157 Slow Release Tablets offer a precisely dosed BPC-157 formulation designed for research settings requiring delayed-release peptide delivery. Each bottle contains 60 tablets, with each tablet providing 820mcg of BPC-157 in a controlled-release format.
Key Features
• BPC-157 Content: Each tablet contains 820mcg of BPC-157.
• Quantity: 60 tablets per container.
• Slow Release Design: Timed-release tablet structure for extended exposure in relevant models.
• Research Focused: Suitable for studies requiring oral delivery and longer duration peptide presence.
• Stable Format: Tablets designed to remain intact until reaching desired conditions in testing models.
Ingredients
• BPC-157 – 820mcg per tablet
• Microcrystalline Cellulose, Magnesium Stearate, Hypromellose (for controlled release)
Storage & Handling
Store in a cool, dry location. Keep container sealed. For laboratory research only.
Disclaimer – Research Use Only
The products on this page are intended for laboratory research use only and are not for human or veterinary use, ingestion, or administration. These materials are not dietary supplements, drugs, or food products, and have not been evaluated by the FDA. They are not intended to diagnose, treat, cure, or prevent any disease or medical condition.
You must be 21 years of age or older to purchase. By accessing or purchasing from this page, you agree to use all products strictly for in vitro research, laboratory, or analytical purposes only and in accordance with all applicable laws and regulations.
Magna GenetX BPC-157 Slow Release Tablets offer a precisely dosed BPC-157 formulation designed for research settings requiring delayed-release peptide delivery. Each bottle contains 60 tablets, with each tablet providing 820mcg of BPC-157 in a controlled-release format.
Key Features
• BPC-157 Content: Each tablet contains 820mcg of BPC-157.
• Quantity: 60 tablets per container.
• Slow Release Design: Timed-release tablet structure for extended exposure in relevant models.
• Research Focused: Suitable for studies requiring oral delivery and longer duration peptide presence.
• Stable Format: Tablets designed to remain intact until reaching desired conditions in testing models.
Ingredients
• BPC-157 – 820mcg per tablet
• Microcrystalline Cellulose, Magnesium Stearate, Hypromellose (for controlled release)
Storage & Handling
Store in a cool, dry location. Keep container sealed. For laboratory research only.
Disclaimer – Research Use Only
The products on this page are intended for laboratory research use only and are not for human or veterinary use, ingestion, or administration. These materials are not dietary supplements, drugs, or food products, and have not been evaluated by the FDA. They are not intended to diagnose, treat, cure, or prevent any disease or medical condition.
You must be 21 years of age or older to purchase. By accessing or purchasing from this page, you agree to use all products strictly for in vitro research, laboratory, or analytical purposes only and in accordance with all applicable laws and regulations.
Serving Size: 1 Tablet
Servings Per Container: 60
BPC-157 - 820mcg
Other Ingredients: Dicalcium phosphate, microcrystalline cellulose, vegetable stearic acid, vegetable magnesium stearate, croscarmellose sodium, silicon dioxide, and aqueous film coating (purified water, hydroxypropyl methylcellulose, and vegetable glycerin).
